Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

A new method effectively predicts estrogen-related health effects for early screening.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

SHBG may be a useful early indicator and treatment target for PCOS.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Non-coding RNAs help control hair growth in cashmere goats.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.